City

Clinical trials near Bethesda, United States

Active studies with a listed research site in Bethesda, United States.

20active studies

17recruiting now

1countries represented

3largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

Overweight, ObesityCondition

Standard Diet, Ketogenic DietTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-04 · NCT06044935See eligibility →

Recruiting nowNot applicable

New Heart Imaging Techniques to Evaluate Possible Heart Disease

Healthy, ObesityCondition

MR Imaging Techniques - 1, MR Imaging Techniques - 2Treatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-03 · NCT01399385See eligibility →

Recruiting nowNot applicable

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Metabolic Disease, ObesityCondition

NSR IDE-MRI: Research pulse sequencesTreatment

United States3 locations

National Heart, Lung, and Blood Institute (NHLBI)Sponsor

Updated 2026-09-01 · NCT01143454See eligibility →

Recruiting nowNot applicable

Physical and Behavioral Traits of Overweight and Obese Adults

Obesity, Healthy VolunteersCondition

Intervention not listedTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-01 · NCT00428987See eligibility →

Recruiting nowNot applicable

Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention

Cardiovascular Disease, ObesityCondition

Intervention not listedTreatment

United States1 locations

National Heart, Lung, and Blood Institute (NHLBI)Sponsor

Updated 2026-09-01 · NCT01927783See eligibility →

Recruiting nowNot applicable

Children s Growth and Behavior Study

Obesity, Eating BehaviorsCondition

Intervention not listedTreatment

United States1 locations

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Sponsor

Updated 2026-09-01 · NCT02390765See eligibility →

Recruiting nowPhase 2

Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)

Healthy Volunteers, OverweightCondition

Sucralose, PlaceboTreatment

United States1 locations

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Sponsor

Updated 2026-09-01 · NCT03407079See eligibility →

Recruiting nowNot applicable

Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments

ObesityCondition

Step it Up mobile app, Global Positioning System (GPS) DeviceTreatment

United States1 locations

National Heart, Lung, and Blood Institute (NHLBI)Sponsor

Updated 2026-08-31 · NCT03288207See eligibility →

Recruiting nowNot applicable

Diabetes and Heart Disease Risk in Blacks

Cardiovascular Diseases, DiabetesCondition

Intervention not listedTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-08-28 · NCT00001853See eligibility →

Recruiting nowPhase 2

Tirzepatide in MetALD

Metabolic Alcohol-associated Liver Disease, Alcohol Use DisorderCondition

Tirzepatide, PlaceboTreatment

United States1 locations

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Sponsor

Updated 2026-08-12 · NCT07046819See eligibility →

Recruiting nowPhase 2

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Non-Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver DiseaseCondition

SemaglutideTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-08-10 · NCT03884075See eligibility →

Recruiting nowNot applicable

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

Obesity, Type 2 DiabetesCondition

Intervention not listedTreatment

United States2 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-08-05 · NCT06730113See eligibility →

Recruiting nowNot applicable

Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change

Overweight, ObesityCondition

Low-carbohydrate Diet, Low-fat DietTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-07-31 · NCT06325722See eligibility →

Recruiting nowPhase 1

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

Alcohol Use Disorder (AUD)Condition

Tirzepatide, PlaceboTreatment

United States1 locations

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Sponsor

Updated 2026-07-28 · NCT07559500See eligibility →

Recruiting nowNot applicable

Mechanisms Underlying Individual Variations of Taste and Smell in Obesity

ObesityCondition

Intervention not listedTreatment

United States1 locations

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Sponsor

Updated 2026-07-22 · NCT04714892See eligibility →

Recruiting nowNot applicable

MEHMO Natural History and Biomarkers

Intellectual Disability, EpilepsyCondition

Intervention not listedTreatment

United States1 locations

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Sponsor

Updated 2026-06-25 · NCT06019182See eligibility →

Recruiting nowNot applicable

Dinner Time for Obesity and Prediabetes

PreDiabetes, ObesityCondition

Early Dinner, Late DinnerTreatment

United States2 locations

Johns Hopkins UniversitySponsor

Updated 2026-04-13 · NCT05745441See eligibility →

Opening soonPhase 2

Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity

Insulin Resistance, ObesityCondition

Alpha-lipoic acid, MirabegronTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-08 · NCT05713799See eligibility →

Opening soonNot applicable

Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults

Obesity, DiabetesCondition

Intervention not listedTreatment

United States1 locations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sponsor

Updated 2026-09-08 · NCT07388537See eligibility →

Invitation onlyNot applicable

Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations

Diabetes, Cardiovascular DiseaseCondition

Intervention not listedTreatment

United States1 locations

National Human Genome Research Institute (NHGRI)Sponsor

Updated 2026-08-07 · NCT01316783See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Bethesda, United States

Current studies

Related cities